SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-13-046296
Filing Date
2013-08-15
Accepted
2013-08-15 15:41:39
Documents
2
Group Members
L&L TECHNOLOGIES, LLCLEDER LABORATORIES, INC.LEDERMAN & CO., LLCSTARLING PHARMACEUTICALS, INC.TARGENT PHARMACEUTICALS, LLC

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A v353110_sc13da.htm SC 13D/A 160271
2 EXHIBIT 1 v353110_ex1.htm EX-1 9146
  Complete submission text file 0001144204-13-046296.txt   171004
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Subject) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86436 | Film No.: 131042141
SIC: 1000 Metal Mining

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
LEDERMAN SETH (Filed by) CIK: 0001563420 (see all company filings)

Type: SC 13D/A